CN

Christopher Ntoumenopoulos

Entropy Neurodynamics Limited | Executive Director
Mr Ntoumenopoulos has over 20 years of experience in financial markets in both capital raising and corporate strategy. He serves as the Managing Director of Twenty1 Corporate, an Australian based corporate advisory firm that provides funding and corporate support for innovative companies and technologies. He is currently a director of Tryp Therapeutics in Canada.

Companies and Roles

Company
Title
Tenure
Since
ENP
ENP
Entropy Neurodynamics Limited
  • Executive Director
2yrs, 5mthMay 2024
MEB
MEB
Medibio Limited
  • Non-Executive Director
3yrs, 8mthFeb 2023
ILA
ILA
Island Pharmaceuticals Limited
  • Non-Executive Director
2yrs, 1mthSep 2024
TRI
TRI
TrivarX Ltd
  • Non-Executive Director
3yrs, 8mthFeb 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TRI
TRI
TrivarX Ltd
13/10/266,250,00014,711,63892,000,000N/A
ENP
ENP
Entropy Neurodynamics Limited
30/06/26N/A19,191,17649,046,580N/A
ILA
ILA
Island Pharmaceuticals Limited
30/06/26N/A2,880,3705,594,568N/A
TYP
TYP
30/06/2516,250,000N/A34,046,580N/A
NSB
NSB
17/11/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TRI
TRI
TrivarX Ltd
13/10/26
Expiry
2,362,500$0.010$23,625Options expired
ENP
ENP
Entropy Neurodynamics Limited
14/04/26
Issued
2,941,176$0.034$100,000Placement
TRI
TRI
TrivarX Ltd
19/12/25
Issued
75,000,000$0.017$1,275,000As advised by the company
TRI
TRI
TrivarX Ltd
19/12/25
Issued
6,250,000$0.008$50,000Placement
TRI
TRI
TrivarX Ltd
19/12/25
Issued
5,000,000$0.008$40,000Placement